Regeneron likely to make coronavirus treatments available in few months

(Reuters) - Regeneron Pharmaceuticals Inc is ramping up efforts to develop a set of coronavirus treatments, which could be available for testing or use in some patients within a few months, the drugmaker said on Thursday.

The drugmaker on Tuesday expanded its arrangement with the U.S. Department of Health and Human Services to collaborate on developing a treatment, joining the race to develop a treatment for the virus that has killed more than 550 people.